加权毒性评分的优缺点。
Advantages and Adversities of the Weighted Toxicity Score.
机构信息
Department of Oncology, Karmanos Cancer Institute/Wayne State University, Detroit, Michigan.
出版信息
Clin Cancer Res. 2018 Oct 15;24(20):4918-4920. doi: 10.1158/1078-0432.CCR-18-1562. Epub 2018 Jul 12.
Abstract
It is imperative to develop a comprehensive toxicity score that will capture, convey, and compare adverse events of agents that are therapeutic options for the same disease state. The weighted toxicity score tool is a valuable aid in the shared decision-making process of therapeutic choice between patients and providers. .
摘要
开发一种全面的毒性评分系统至关重要，该系统能够捕捉、传递和比较针对同一疾病状态的治疗选择药物的不良事件。加权毒性评分工具是患者和提供者在治疗选择的共同决策过程中的有价值的辅助工具。
相似文献
1
Advantages and Adversities of the Weighted Toxicity Score.加权毒性评分的优缺点。
Clin Cancer Res. 2018 Oct 15;24(20):4918-4920. doi: 10.1158/1078-0432.CCR-18-1562. Epub 2018 Jul 12.
2
The comparative effectiveness of decision aids in diverse populations with early stage prostate cancer: a study protocol for a cluster-randomized controlled trial in the NCI Community Oncology Research Program (NCORP), Alliance A191402CD.不同人群早期前列腺癌决策辅助工具的比较效果：NCI 社区肿瘤学研究计划（NCORP）、联盟 A191402CD 中的一项集群随机对照试验研究方案。
BMC Cancer. 2018 Aug 6;18(1):788. doi: 10.1186/s12885-018-4672-3.
3
Tailoring and evaluating an intervention to improve shared decision-making among seniors with dementia, their caregivers, and healthcare providers: study protocol for a randomized controlled trial.定制和评估一项干预措施以改善老年痴呆症患者、其护理人员和医疗服务提供者之间的共同决策：一项随机对照试验的研究方案
Trials. 2018 Jun 25;19(1):332. doi: 10.1186/s13063-018-2697-1.
4
Development and Pilot Testing of an Encounter Tool for Shared Decision Making About the Treatment of Graves' Disease.一种用于格雷夫斯病治疗共同决策的会诊工具的开发与初步测试
Thyroid. 2015 Nov;25(11):1191-8. doi: 10.1089/thy.2015.0277. Epub 2015 Oct 15.
5
Decision aids for people facing health treatment or screening decisions.为面临医疗治疗或筛查决策的人们提供的决策辅助工具。
Cochrane Database Syst Rev. 2001(3):CD001431. doi: 10.1002/14651858.CD001431.
6
Shared decision making in patients with low risk chest pain: prospective randomized pragmatic trial.低风险胸痛患者的共同决策：前瞻性随机实用试验。
BMJ. 2016 Dec 5;355:i6165. doi: 10.1136/bmj.i6165.
7
A shared decision-making tool for obstructive sleep apnea without tonsillar hypertrophy: A randomized controlled trial.一种用于无扁桃体肥大的阻塞性睡眠呼吸暂停的共同决策工具：一项随机对照试验。
Laryngoscope. 2018 Apr;128(4):1007-1015. doi: 10.1002/lary.26967. Epub 2017 Nov 8.
8
Decision aids to improve informed decision-making in pregnancy care: a systematic review.决策辅助工具以改善妊娠护理中的知情决策：系统评价。
BJOG. 2013 Feb;120(3):257-66. doi: 10.1111/1471-0528.12060. Epub 2012 Nov 12.
10
Protocol of a randomized controlled trial of an erythropoietin stimulating agent decision aid for anemia treatment in kidney disease.一项关于促红细胞生成素刺激剂决策辅助工具用于肾病贫血治疗的随机对照试验方案。
BMC Nephrol. 2016 Jul 18;17(1):86. doi: 10.1186/s12882-016-0301-z.
引用本文的文献
1
Development and Implementation of Proton Therapy for Hodgkin Lymphoma: Challenges and Perspectives.霍奇金淋巴瘤质子治疗的发展与实施：挑战与展望
Cancers (Basel). 2021 Jul 26;13(15):3744. doi: 10.3390/cancers13153744.
本文引用的文献
1
A Method to Summarize Toxicity in Cancer Randomized Clinical Trials.一种总结癌症随机临床试验中毒性的方法。
Clin Cancer Res. 2018 Oct 15;24(20):4968-4975. doi: 10.1158/1078-0432.CCR-17-3314. Epub 2018 May 8.
2
Evolving Treatment Paradigm in Metastatic Renal Cell Carcinoma.转移性肾细胞癌不断演变的治疗模式
Am Soc Clin Oncol Educ Book. 2017;37:319-329. doi: 10.1200/EDBK_174469.
3
The Imperative for a New Approach to Toxicity Analysis in Oncology Clinical Trials.肿瘤临床试验中进行毒性分析的新方法势在必行。
J Natl Cancer Inst. 2015 Aug 1;107(10). doi: 10.1093/jnci/djv216. Print 2015 Oct.
4
Patient-reported outcomes and the evolution of adverse event reporting in oncology.患者报告的结局与肿瘤学中不良事件报告的演变
J Clin Oncol. 2007 Nov 10;25(32):5121-7. doi: 10.1200/JCO.2007.12.4784.
5
Assessing the reliability of two toxicity scales: implications for interpreting toxicity data.评估两种毒性量表的可靠性：对毒性数据解读的启示
J Natl Cancer Inst. 1993 Jul 21;85(14):1138-48. doi: 10.1093/jnci/85.14.1138.
Zotero 插件